Page last updated: 2024-10-18

dihydroxyphenylalanine and Carcinoma, Small Cell

dihydroxyphenylalanine has been researched along with Carcinoma, Small Cell in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacob, T1
Grahek, D1
Younsi, N1
Kerrou, K1
Aide, N1
Montravers, F1
Balogova, S1
Colombet, C1
De Beco, V1
Talbot, JN1

Trials

1 trial available for dihydroxyphenylalanine and Carcinoma, Small Cell

ArticleYear
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:9

    Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans;

2003